p phenotype

Common Name(s)

p phenotype

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "p phenotype" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "p phenotype" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "p phenotype" returned 52 free, full-text research articles on human participants. First 3 results:

Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.
 

Author(s): Beáta Csányi, Lidia Hategan, Viktória Nagy, Izabella Obál, Edina T Varga, János Borbás, Annamária Tringer, Sabrina Eichler, Tamás Forster, Arndt Rolfs, Róbert Sepp

Journal: Int Heart J. 2017 May;58(3):454-458.

 

Fabry disease (FD) is an X-linked inherited lysosomal storage disorder caused by mutations in the GLA gene, encoding for the enzyme α-galactosidase A. Although hundreds of mutations in the GLA gene have been described, many of them are variants of unknown significance. Here we report ...

Last Updated: 12 May 2017

Go To URL
Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene.
 

Author(s): Johanna Palmio, Satu Sandell, Michael G Hanna, Roope Männikkö, Sini Penttilä, Bjarne Udd

Journal: Neurology. 2017 Apr;88(16):1520-1527.

 

To characterize the clinical phenotype in patients with p.A1156T sodium channel mutation.

Last Updated: 23 Mar 2017

Go To URL
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.
 

Author(s): Roberta Zuntini, Laura Cortesi, Daniele Calistri, Tommaso Pippucci, Pier Luigi Martelli, Rita Casadio, Elisa Capizzi, Donatella Santini, Sara Miccoli, Veronica Medici, Rita Danesi, Isabella Marchi, Valentina Zampiga, Michelangelo Fiorentino, Simona Ferrari, Daniela Turchetti

Journal: Oncotarget. 2017 Apr;8(14):22640-22648.

 

We have investigated the clinical significance of the BRCA1 variant p.His1673del in 14 families from the Emilia-Romagna region of Italy, including 20 breast and 23 ovarian cancer cases; four families displayed site-specific ovarian cancer.The variant, absent in human variation databases, ...

Last Updated: 10 Feb 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "p phenotype" returned 1 free, full-text review articles on human participants. First 3 results:

A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens.
 

Author(s): Laura Cooling, Louann R Dake, Donna Haverty, Nancy Mullis, Susie Ellis, James Shayman, W John Judd

Journal: Transfusion. 2015 Jan;55(1):115-28.

 

"Weak P" is a rare red blood cell (RBC) phenotype, characterized by a global decrease in P(k) and P antigens. We now describe a second weak P individual who also typed LKE-negative (LKE-N) and possessed a clinically significant anti-LKE.

Last Updated: 13 Jan 2015

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
 

Status: Recruiting

Condition Summary: Lung Neoplasms

 

Last Updated: 7 Nov 2017

Go to URL
Evaluation of Pupillometry for cyp2d6 Phenotyping in Children Treated With Tramadol
 

Status: Recruiting

Condition Summary: Drug Intolerance; Cytochrome P450 CYP2D6 Enzyme Deficiency; Drug Effect

 

Last Updated: 2 May 2017

Go to URL